ArticlePLoS medicine2015
Value of Information: A Tool to Improve Research Prioritization and Reduce Waste.
Article in PLoS medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical Trial.PharmacoEconomics · 2026Review
- Cost-effectiveness of combined veno-arterial extracorporeal membrane oxygenation and Impella support (ECPELLA) in infarct-related cardiogenic shock.European heart journal open · 2026Article
- Economic Analyses for Disease Surveillance Planning and Advocacy.The Journal of infectious diseases · 2025Article
- Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.PharmacoEconomics · 2024Article
- What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.International journal of health policy and management · 2023Article
- Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas.Pituitary · 2022Article
- Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity.Medical decision making : an international journal of the Society for Medical Decision Making · 2022Article
- Prioritizing nurturing care at the municipal and district level with the Brazilian Early Childhood Friendly Municipal Index (IMAPI).Maternal & child nutrition · 2022Article
- Methods for Identifying Health Research Gaps, Needs, and Priorities: a Scoping Review.Journal of general internal medicine · 2022Article
- Prioritisation and design of clinical trials.European journal of epidemiology · 2021Article
- Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review.PharmacoEconomics - open · 2020Review
- The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research.Health research policy and systems · 2019Article
- Error associated with estimates of Minimum Infection Rate for Endemic West Nile Virus in areas of low mosquito trap density.Scientific reports · 2019Article
- A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019Article
- Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.Annals of the American Thoracic Society · 2019Observational
- When Is Enough, Enough? When Are More Observational Epidemiologic Studies Needed to Resolve a Research Question: Illustrations Using Biomarker-Cancer Associations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019Article
- Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression.ClinicoEconomics and outcomes research : CEOR · 2019Article
- Article
- Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed.BMC cardiovascular disorders · 2017Article
- Predictive Assessment of Cancer Center Catchment Area from Electronic Health Records.Frontiers in public health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In a Guest Editorial, Cosetta Minelli and Gianluca Baio explain how VOI analysis can prioritize research projects by identifying uncertainty in existing knowledge and then estimating expected benefits from reducing that uncertainty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.